PENUMBRA SYSTEM REPERFUSION CATHETER 054
Report
- Report Number
- 3005168196-2012-00107
- Event Type
- Death
- Date Received
- March 23, 2012
- Date of Event
- February 19, 2012
- Report Date
- February 28, 2012
- Manufacturer
- PENUMBRA, INC.
- Product Code
- NRY
- PMA / PMN Number
- K090752
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
CONCLUSION: EMBOLI IS A KNOWN AND ANTICIPATED COMPLICATION WITH THESE TYPES OF PROCEDURES AND IS NOTED IN THE DEVICE LABELING. THEREFORE, IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, QUALITY, OR DESIGN CONCERNS. DEVICE DISCARDED BY THE HOSPITAL.
THE REPERFUSION CATHETER 054 WAS USED TO ASPIRATE CLOTS N THE C2 SEGMENT OF THE LEFT INTERNAL CAROTID ARTERY (ICA). AFTER THE C2 WAS OPENED, ADDITIONAL EMBOLI CAUSED REOCCLUSION. A BALLOON PTA PROCEDURE WAS USED TO REOPEN THE C2 BUT IT OCCLUDED AGAIN. A STENT WAS PLACED WITH PTA AT THE C2 SEGMENT BUT STILL THE OCCLUSION REMAINED. THE PHYSICIAN DECIDED TO END THE PROCEDURE. THE PHYSICIAN NOTED ATHEROSCLEROTIC PLAQUE AT THE SITE OF THE LESION WHICH CAUSED THE EMBOLI. HE WAS NOT SURE WHICH DEVICE CAUSED RUPTURE OF THE PLAQUE AND THE RELEASE OF DISTAL EMBOLI. INTRAVENOUS OZAGREL WAS ADMINISTERED TO THE PATIENT AFTER TREATMENT. THE PATIENT DIED ON (B)(6) 2012. THE PHYSICIAN COMMENTED THAT ADDITIONAL TREATMENTS COULD NOT HAVE PREVENTED THE REOCCLUSION. THE PATIENT WAS CONTRAINDICATED FOR T-PA; THEREFORE, IT WAS NOT ADMINISTERED; HOWEVER, IT WAS NOTED THAT IT MIGHT HAVE LEAD TO A DIFFERENCE IN THE OUTCOME.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | PENUMBRA SYSTEM REPERFUSION CATHETER 054 | NRY | NRY | PENUMBRA, INC. | F23249 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR | Death| O |